| PubChemBioAssay Name | AIDs | Probe Type | Assay Type | Assay Format | Assay Detection & well format | Responsible Center |
|---|---|---|---|---|---|---|
| Summary Assay for the inhibition of Hepatic Lipid Droplet Formation. | 1658 | Inhibitor | Summary | N/A | N/A | SBCCG |
| High Throughput Imaging Assay for Hepatic Lipid Droplet Formation. | 1656 | Inhibitor | Primary | HCS | Fluorescence (staining) & 384-well | SBCCG |
| Single concentration confirmation of HCS identification of small molecules that inhibit hepatic lipid droplet formation | 463183 | Inhibitor | Confirmatory (Cherry Pick) | HCS | Fluorescence (staining) & 384-well | SBCCG |
| Dose response confirmation of HCS identification of small molecules that inhibit hepatic lipid droplet formation | 463191 | Inhibitor | Confirmatory (Dose Response) | HCS | Fluorescence (staining) & 384-well | SBCCG |
| SAR Analysis for the identification of small molecules that inhibit hepatic lipid droplet formation using an image based screen. | 493092; 504440 | Inhibitor | Confirmatory (Dry Powder) | HCS | Fluorescence (staining) & 384-well | SBCCG |
| SAR Analysis for the identification of small molecules that inhibit hepatic lipid droplet formation in human hepatocytes using an image based screen. | 504422 | Inhibitor | Secondary (Dry Powder) | HCS | Fluorescence (staining) & 384-well | SBCCG |
| Counterscreen for Detection of Compound Cytotoxicity in Hepatocytes (AML12 cells) | 463219; 463200 | Inhibitor | Secondary (Dose Response) | HCS | Fluorescence (staining) & 384-well | SBCCG |
| SAR analysis of compound cytotoxicity in hepatocytes (AML12 cells) – by ATPLite™ | 504443 | Inhibitor | Secondary (Dry Powder) | HCS | Fluorescence (staining) & 384-well | SBCCG |
From: Potent inhibitors of lipid droplet formation
NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.